Comparision of analgesia in postoperation painof cholesystectomy
Phase 3
- Conditions
- cholesystectomy.Acute cholecystitisK81.0
- Registration Number
- IRCT20180723040570N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Patient consent
Cholesystectomy for first time
Exclusion Criteria
Absence of addiction during 24 hours before surgery
Absence of allergic reaction to drugs
Absence of addiction of alcohol and drugs
Absence of chronic pain disorder
Absence of neurological disease or chronic usage of steroids
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain that means anything bothers patients physically and mentally. Timepoint: Ricovery and 2,8,24 hours after surgery. Method of measurement: visual analogue scale.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie bupivacaine's analgesic effects in post-cholecystectomy pain?
How does intraperitoneal bupivacaine compare to standard opioid-based analgesia in laparoscopic cholecystectomy outcomes?
Are inflammatory biomarkers like IL-6 or CRP predictive of response to bicarbonate irrigation post-cholecystectomy?
What adverse events are associated with intraperitoneal bupivacaine versus bicarbonate in phase III cholecystectomy trials?
Do combination approaches with bupivacaine and COX-2 inhibitors enhance postoperative pain relief in K81.0 patients?